Aurion Biotech

Great companies are led by great people. Congrats to @gregkunst and thanks to @PSBJ for this Healthcare Leadership award! bizjournals.com/seattle/news/2…

So proud that we have received this honor! aurionstaging.wpengine.com/aurion-regener…

Edward J. Holland, MD, and Shigeru Kinoshita, MD, PhD, discuss the U.S. phase 1/2 trial for @AurionBiotech's AURN001 #celltherapy for #cornealedema, which was invented by Kinoshita and just dosed its first patient last month. Find out more 🔗: bit.ly/40teAnt

Terrific conversation on challenges of C&GT manufacturing in a changing world. #cgmesa2023

@Healio_OSN @OSNNewYork thanks to OSN for including us in a terrific conference

Greg Kunst shares the Aurion Biotech story on cell therapy for endothelial corneal disease ⁦@OSNNewYork⁩

Great companies, in great company! Honored for Aurion to share BioFuture Stage with @endpts @leileiwuu, Sean Ainsworth @Immusoft, Christine Silverstein @ExcisionBio, Liz Wood @JuraBio to talk about the future of cell and gene therapy: how it will transform patient care.

Dr. Matt Giegengack presenting Escalon trial 12-month data here at ASCRS

ASCRS Live: Aurion BioTech shares 12-month data from our recent Escalón trial ophthalmologytimes.com/view/ascrs-liv…

please that our chief scientific officer asked to speak to CGTLive! ow.ly/WaKp50O1kKc

@CGT_Live ow.ly/WaKp50O1kKc

@CGT_Live pleased that our Chief Scientific Officer asked to speak to CGTLive!

Lacoste discussed the findings of the research @AurionBiotech presented at #ARVO2023, noting that the study provided evidence that AURN001 cells contribute to immune privilege in the anterior chamber of the eye. Watch now: ow.ly/WaKp50O1kKc

Congrats to our inspiring inventor, Prof Shigeru Kinoshita, for being named to the Power List!urldefense.proofpoint.com/v2/url?u=https…

Terrific panel at Reuters Pharma USA 2023!

Important milestone for millions of patients suffering from corneal endothelial disease aurionbiotech.com/aurion-biotech…

Excited that Jon Sparks, JD, PhD joins Aurion as Chief Legal Officer! aurionbiotech.com/jonathan-spark…

@GalienFdn thanks to Galien Foundation for this incredible honor

Congrats to the 2022 #PrixGalien “Best Startup in Pharmaceutical or Biotechnology Industry” winner @AurionBiotech for its patented cell therapy treatment for corneal endothelial disease. Learn more: galien.org/3TNl3FH

Arnaud Lacoste, Chief Scientific Officer at @AurionBiotech talks about the new cell therapy for corneal endothelial dystrophy and its potential to change corneal surgery 👀 bit.ly/3Mr8Ljj